Bristol Myers Squibb (BMY) Buildings (2015 - 2026)

Bristol Myers Squibb (BMY) has 12 years of Buildings data on file, last reported at $7.5 billion in Q1 2026.

• Quarterly Buildings rose 12.74% year-over-year to $7.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 billion (up 12.74% YoY) and the FY2025 annual result came in at $7.3 billion, up 10.47% from the prior year.
• Buildings advanced to $7.5 billion in Q1 2026 per BMY's latest filing, from $7.3 billion in the prior quarter.
• Across five years, Buildings topped out at $7.5 billion in Q1 2026 and bottomed at $5.7 billion in Q2 2022.
• The 5-year median for Buildings is $6.5 billion (2023), against an average of $6.5 billion.
• The widest annual swing landed in 2022, when Buildings gained 0.09%; it then increased 12.74% in 2026.
• Tracing BMY's Buildings over 5 years: stood at $5.9 billion in 2022, then climbed by 9.71% to $6.5 billion in 2023, then grew by 1.32% to $6.6 billion in 2024, then grew by 10.47% to $7.3 billion in 2025, then grew by 2.97% to $7.5 billion in 2026.
• Per Business Quant, the three latest BMY Buildings figures stand at $7.5 billion (Q1 2026), $7.3 billion (Q4 2025), and $7.1 billion (Q3 2025).

Peer Comparison